Search

marijuana inc - search results

If you're not happy with the results, please do another search

0 157

Easton Pharmaceuticals Executes Letter of Intent and Provides Details on Green Patient Network’s Business Plan

TORONTO, ON–(Marketwired – Dec 12, 2014) – Easton Pharmaceuticals (OTC: EAPH) announces it has executed a letter of intent with Canadian Medical Marijuana Club Inc and initiated negotiations to enter the Legal Medical Marijuana prescription access business.

Easton is negotiating a first of its kind in the Canadian medical marijuana industry by having Green Patient Network offered to the public. Green Patient Network should see synergies that present itself from Easton’s Vaporizer customers and the overlap in users which can directly help reduce current patient acquisition costs. Any prospective patient wishing to become a legal Canadian Medical Marijuana Card holder and member can find great value in the services offered by becoming a member of Medical Marijuana Club / Green Patient Network(GPN). Current Market targeted scope will include the major metro area’s in the Canadian marketplace (Vancouver, Calgary and Toronto). In march 2014 there were approximately 40,000 Legal Medical Marijuana Prescription holders in Canada. (Source Health Canada) Currently it is believed that number has increased to 60,000-70,000 patients. Growth in the patient population is being hampered as potential marijuana patients find it is still not an open acceptable subject to discuss their needs with their healthcare provider. Some MMPR un-informed doctors will not easily prescribe Medical Marijuana to their patients due to undue scrutiny placed on them by Health Canada, the RCMP and other regulators.

These underserved patients who suffer from Autism, Epilepsy, Dementia, Diabetes, Glaucoma, Tourette Syndrome, Cancer, PTSD and other ailments are in search of services such as the one being negotiated as a supplement to their current plan of care.

What the Green Patient Network Service Provides :

– Provides Canadian patients looking to obtain legal access with specialized online physician consultations via tele health.

– Connects underserved patients with a trusted network of doctors who advocate working with Licensed Providers within the framework of Canada’s MMPR network.

– Marijuana Licensed Provider prescription management and Marijuana batch number tracking services. This removes the stress of patients having to worry about losing their prescription or having to monitor if any recall’s are made by their LP provider.

– Nursing support line for any patients/ Members who have an adverse reaction to any Marijuana related product.

- Pre Qualification Questionnaire that helps make the entire process easy to understand for the patient.

Costs of this service: membership dues for a single are $375 annually or $150 initial and $30 each monthly subscription model.

Easton Pharmaceuticals Plans to provide updates on these fast moving negotiations in the Legal Medical Marijuana prescription access business within the next 7 to 15 days.. These negotiations are in no way detracting from other negotiations that are being done in the Medical Marijuana space in the United States or other business segments which we plan to divulge within the next week to 10 days.

In other news Easton Pharmaceuticals plans to update its shareholders on prior partnerships made and progress made with AMFIL Technologies and its GrowZone joint venture. Its current adoption has been proceeding well and revenue recognition is slated for this quarter on shipments made within the second Quarter of 2015.

In other news Easton and / or its representatives plans on attending the upcoming Emerald Cup.

About Easton Pharmaceuticals

Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The Company previously owned an FDA approved wound healing drug and currently owns topically-delivered drugs and therapeutic / cosmetic healthcare products focused on cancer and other health issues geared towards female sexual dysfunction, wound healing, pain, motion sickness and other conditions that are all in various stages of development. The company has ventured into the potentially lucrative medical marijuana industry through an investment into AMFIL Technologies and their groZONE anti-bacterial system and the exclusive option to purchase up to 49% in a medical marijuana grow-op business / facility which has received a letter to build from Health Canada. The company’s gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.

For More Information Visit:

http://www.eastonpharmaceuticalsinc.com

http://finance.yahoo.com/q?s=eaph

https://twitter.com/eastonpharma

Safe Harbor

This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The “Act”). In particular, when certain words or phrases such as “hope”, “positive”, “anticipate,” “pleased,” “plan,” “confident that,” “believe,” “expect,” “possible” or “intent to” and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative and may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company’s products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company’s financial reports and filings.

Contact:
Carla Pepe
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email: info@eastonpharmaceuticalsinc.com

0 551

By Michael Berger

Players Network Inc. (PNTV: OTCQB), is a diversified holding company that is focused on two primary industries, media and medical marijuana. PNTV offers investors the opportunity to invest in a diversified cannabis company that is levered to the legal Nevada marijuana market. PNTV is a one of the only fully reporting companies that has received a license to cultivate and process cannabis. This fact gives us a sense of confidence that PNTV is one of the more legitimate OTC traded marijuana stocks.

Entrance into the marijuana space

In late July, PNTV formed Green Leaf Farms Holdings, Inc. The company used Green Leaf to enter the legal medical marijuana industry and apply for a medical marijuana dispensary in Nevada. A few months later, Green Leaf’s application was approved by the state of Nevada for an edible extraction facility. The facility will be located on a 3.2 acre piece of property purchased by Green Leaf. The land which they purchased is able to support a 70,000 square foot facility which will easily be able to satisfy demand. PNTV owns 80% of Green Leaf Farms Holdings with the remaining 20 percent held by key advisors and experts.

The company is working diligently to hopefully commence operations by mid-2015. These operations will provide PNTV with a source of revenue that will enable the company to continue to grow and invest in profitable business ventures. The company believes that the facility can generate $12 to $14 million in annual revenue in its first year of operation. They expect total revenue generated by the facility to increase year over year as demand grows.

Unique business model can create synergies for their two business units

PNTV is also actively involved in the media industry through their proprietary channels. This offers the company another source of revenue, and free exposure for their marijuana business. The company will use WeedTV.com, one of their proprietary channels to increase exposure for Green Leaf. This channel also generates revenues through advertising, cross selling with other companies and premium membership subscriptions.

The company has a unique advantage that makes them an interesting play in the cannabis space. PNTV is able to utilize their two businesses units to create synergies for each other and increase total revenues. These revenues will lead to higher margins, which will improve the company’s bottom line if they are able to execute on their business plan.

Strong management team

PNTV has been around since the early 1990s and they have created many strategic relationships that strengthen the company’s footprint. The company’s CEO and founder, Mark Bradley founded Players Network in 1993 and has served as CEO since the company’s inception. Bradley has been a producer/director at United Artists, and was studio manager and postproduction supervisor with United Cable Television in Los Angeles, engaged in the production, packaging and syndication of television and film productions for such media venues as HBO, Nickelodeon and MTV.

The company’s Chief Creative Officer, Michael Berk, is a prolific writer, producer and director with over three hundred hours of television programming to his credit. Berk created and Executive produced “Baywatch,” the most popular series in television history, and is currently producing a large-budget “Baywatch” feature film for Paramount.

Leslie Thomas is the marketing and operations manager for PNTV. Thomas works directly with major media outlets, including: Comcast Communications, DirecTV, AT&T, Verizon, and TivoCast, as well as multiple broadband sites.

The marketing and licensing advisor, John Raczka, has a proven track record of success in driving revenue growth in the linear, interactive and gaming entertainment sectors worldwide.

Edward Sullivan serves as the company’s media, branding, and marketing advisor. Sullivan has overseen the brand & marketing efforts for over 50 launches and re-launches of major media companies including: CBS, ABC, FOX, Discovery Networks, Turner Broadcasting, HBO and Disney cable networks.

Doug Miller serves on the board of PNTV and brings over thirty years of hands-on operating experience to the Players Network Board. Focusing on high growth start-up and turnaround companies, Mr. Miller participated in leading four companies to IPO´s. Mr. Miller holds a B.A. from the University of Nebraska and an MBA from Stanford University.

Outlook

PNTV’s entrance into the medical marijuana market offers a lot of upside to current estimates, however the stock has not reacted favorably to this. PNTV is down over 10% since early November even though the story has improved. Technical420 thinks that the company has the potential to be player in the cannabis industry due to their unique business model and the synergies that can be created between Weed TV and Green Leaf Farms Holdings. However, the current trading pattern of PNTV keeps Technical420 on the sidelines until an upward price trend is formed, or until positive guidance is released regarding their Nevada operations.

0 2120

Written By: Michael Berger

Over the course of 2014, we have seen the cannabis industry expand at rate that has not been seen since the days of the Tech Boom. Over one hundred companies have gone public through reverse mergers and entered the rapidly developing cannabis industry during 2014.

Currently, twenty-three states allow the use of medical marijuana and two allow the use of recreational marijuana. With three states (Oregon, Alaska and the District of Columbia) voting on legalizing recreational marijuana, and Florida voting on medical marijuana, the market is poised to continue to grow at a rapid rate during 2015. The legal cannabis industry (medical and recreational) is expected to generate over $3 billion in revenue during 2014 and Technica420 expects these numbers to more than double during 2015.

 

To start let’s focus on the states that have legalized marijuana for recreational use

Colorado

  • For the first time in July 2014, recreational sales surpassed medical.

recreational

  • Fiscal Year 2014-2015 is estimated to generate over $47M in tax revenue for Colorado.
  • Colorado’s monthly marijuana tax has doubled since January 2014
  • As of July 2014, over 200 marijuana dispensaries were licensed according to the Colorado Department of Revenue
  • Beginning in July 2014, having Colorado residency qualifies you to apply for a retail marijuana business license. (Small business boom hasn’t even begun!)

Washington

  • Recreational sales doubled month over month. July generated $3.2M compared to $7M in August. (100% Growth; not even operating at maximum production/distribution)
  • Washington collected $2.5M in excise taxes from the first 2 months ($10M) or 25% of sales.
  • The numbers in Washington are set to grow significantly as the supply chain becomes more structured in a way that matches growing demand. Also more retail dispensaries opening will contribute to that growth and supply chain structure

 

This industry has not even entered the first inning of what will be a multi decade growth cycle. The upcoming November elections, coupled with government deregulation leads to the possibility that the market will continue to grow exponentially (like we saw during the beginning of 2014).

 

As marijuana stocks continue their STEEP sell off, some are down more 90% from March 2014 highs, the sector could be forming a bottom and setting up for a major explosion entering 2015!

Historical data illustrates some reassuring signs for marijuana investors. Marijuana stocks tend to reverse their momentum from bearish to bullish in the fall, especially during an election year, and this usually lasts until February/March. Many of these stocks are trading at price levels lower than they were last year before they took off.

Technical420 is no way affiliated with “The Benzinga Marijuana Index”, however we understand that marijuana investors use it as a benchmark for the sector. Please be aware that the index is a composite of the stock tickers in the marijuana sector and it DOES NOT illustrate whether an individual stock is over/under valued. As you can see from the image below, the index is trading near the same level it was before Colorado’s legalized marijuana market took effect.
chart

On November 4th, several major states are voting on marijuana initiatives. Voters have expressed more support for legalized marijuana than ever before. We have seen companies expand, and move their operations to states that have marijuana on their ballot during November. These companies are poised to benefit off of deregulation and we would keep an eye on these stocks as we wait for a bottom to form.

0 287

If you thought nothing exciting happens over the weekend, you are wrong. This past weekend Congress passed a massive federal spending measure; we’re talking $1.1 trillion dollars. The exciting part is that the bill also included a provision that will put an end to the federal government’s ban on medical marijuana. The measure means that the federal drug agents would not be able to raid legal medical marijuana dispensaries in all of the 32 states and Washington D.C., that have legalized medical cannabis. It is expected that President Obama will sign off on the spending bill this week, which would then make it a law.

Democrat Rep. Sam Farr, of California said, “This is a victory for so many, Congress’ approval of the measure marked the first time in decades that the federal government has curtailed its oppressive prohibition of marijuana.”

Even if the law does get signed into action, marijuana is still considered a Schedule 1 drug, “with no accepted medical use”, according to the DEC. Sounds like a catch 22.

The bill wasn’t all good news for pot advocates though. There is another provision in the bill that has the potential to overturn the recreational marijuana initiative that voters approved in Washington D.C. last month.

Republican Rep. Andy Harris of Maryland, who has opposed marijuana laws, introduced the amendment.

“D.C. is not a state,” Harris said in his defense last week. “I’m sorry, it’s not a state.”

0 896

Submitted by: Joe S.

“New Interest In The Market Promotes Positive Potential For This Pot (Hemp) Player”

To date, Totally Hemp Crazy Inc. (OTCPK:THCZ) has been sparse with its corporate updates and announcements having the single outliers being a shareholder update in October and an August PR discussing plans for launching the company’s hemp infused beverage products, while, of course, bringing on a marketing company to help. Unfortunately that announcement came AFTER the stock’s run up to highs that scraped nearly 5 and a half cents. Since then the stock has continued to decline…up until this week.

It would appear that there’s become a growing interest in the stock following the Company’s most recent announcement that it is preparing for the initial product run of its proprietary hemp infused beverage line. So this made me wonder: Why?

Rhino Marketing Worldwide & Red Bull

After doing a little digging (and fortunately enough the information was easily accessible), I found that this marketing company, Rhino Marketing Worldwide, is no stranger to being involved with major international product launches and fast moving consumer retail products. Rhino had a hand in working with the likes of Wolfgang Puck Iced Coffee, Nissan, Stryker Orthopedics, the National Football League, and non other than energy drink king, Red Bull!

So putting two and two together (and obviously this is my own opinion), if THCZ is on the verge of rolling out its first production to pilot markets and then nationwide, it would be in the company’s best interest to involve a firm that has a seasoned, well versed firm that knows the landscape and how to successfully navigate it. If Red Bull was part of their track record then I would assume that Rhino will be putting its best foot forward in guiding Totally Hemp Crazy down a similar path.

A Double What?

In fact, since making the announcement, THCZ shares have jumped as high as $0.013 and on top of this “crazy” relationship that the company has with possibly one of RedBull’s integral marketing cogs, the technical set-up for THCZ is suggestive of a reversal in my personal opinion.

The tell tale signs of a “bullish reversal” pattern known as a “double bottom” according to stockcharts.com are as follows:

  1. An existing downtrend prior to a reverse
  2. The formation of the first trough
  3. An advance taking place, following the first trough
  4. …A second trough (starting to get the picture?)
  5. A noticeable advance from the second trough

After step five is when the trend confirms and this is what I’m looking for with THCZ as it has just begun to see some re-interest from the market:

THCZ
Right here we see a very obvious downtrend, two troughs, the inclusion of some above average volume coming into the market suggesting this should be a strong level of support and now the only thing left is to see if THCZ breaks through its previous resistance to solidify the “double bottom” pattern.

Conclusion

The sectors related to marijuana including hemp, medical marijuana, CBD’s, vape pens, and edibles have all gained incredible amounts of attention this year. But more importantly for THCZ is that it is working with a 20 year old veteran in the marketing business who has been a part of some of the biggest names in new product roll-outs. Couple this with the latest attention that the company has begun to receive and throw in that chart for giggles and there could be a very viable argument as to why I feel THCZ could be poised for a new breakout trend before the end of the year.

0 393

by Anthony DelCioppo
@spacenectar

According to the FBI’s Uniform Crime Report there were about 693,481 arrests on marijuana-related charges in 2013, with about 88 percent of those arrests being for possession. Erik Altieri of NORML (National Organization for the Reform of Marijuana Laws) said on NORML’s website a couple of weeks ago that he estimates at least $457 million was spent on arresting individuals for marijuana possession in 2013.

Though estimates and projections vary, some economists say that marijuana prohibition could be costing our government $20 billion a year. Jeffery Miron, a lecturer at Harvard University, estimates that $8.7 billion would be saved by ending prohibition and another $8.7 billion would be generated in tax revenue.

So what could we do with an extra $20 billion a year?

Let’s take a look at a few programs that our taxes pay for…

Education: With an extra $20 billion we could hire over half a million more teachers at an average salary of $36,141, or, we could just pay the good ones more.

National Defense: I don’t even want to get started on this, but $20 billion could barely buy 57 B-2 Spirit bombers, so, not much help here with an $800 billion defense budget.

Law Enforcement: Tax payers pay about $34 billion a year for law enforcement, of which $450,000,000+ is used to turn around and arrest people for possession of the very drug that could save the tax payers $8.7 billion and generate another $8.7 billion in tax revenue.

NASA: $20 billion could fund NASA for over a year. In fact, if you go back to 1958 (NASA’s inception) NASA has only spent about $600 billion in 56 years. Let’s put that in perspective – NASA’s entire 56 year budget has cost tax payers $200 billion less than 1 year of our $800 billion National Defense budget.

U.S. Veteran Benefits: The VA employs nearly 280,000 people with an annual budget of about $87 billion. An internal VA audit released in June of this year, found that more than 120,000 veterans were left waiting or never got care; think a 23% increase in funding could help get our Veterans the health care they need?

National Debt: In 2013 the government paid out $222 billion in interest alone on our $16.74 trillion national debt. Ending marijuana prohibition could help pay about 10% of the annual interest on our national debt.

If you’re suffering from vertigo from reading these statistics don’t worry, it’s not you that’s upside down; it’s our government’s egregious stance on marijuana as a Schedule I drug.

Marijuana legalization is so enigmatic that just weeks after Washington D.C. voted to legalize marijuana recreationally, congress introduced a bill designed to block the legalization of recreational use in D.C.

Yet in the same week, The Department of Justice announced that they will no longer prosecute federal laws regulating the growing or selling of marijuana on Native American reservations, even if state laws say otherwise.

So in case you’re confused about the government’s stance on marijuana, here’s a recap:

  • Marijuana is classified as a Schedule 1 drug, meaning the DEA considers it a dangerous substance that has no recognized medical use and has a high potential for abuse (heroin is also considered a Schedule 1 drug).
  • 23 states and Washington D.C. have legalized marijuana medicinally including 4 states fully recreational (Alaska, Colorado, Oregon, Washington).
  • The Obama Administration has said that it would not challenge laws legalizing marijuana, yet the DEA continues to raid marijuana grow operations in states where marijuana is legal.
  • The Department of Justice announced that it will let tribal governments decide what to do with marijuana on the 326 federally recognized Native American Reservations.
  • The government spent nearly a half billion dollars in tax payer money to arrest people for marijuana possession in 2013.

So as of now the government’s official stance is, uh… ‘Let the states and Native Americans decide what to do about marijuana. Then, we’ll continue to usurp the authority we granted the states and/or tribes, using their own tax money to arrest them for possession of the very thing we said we wouldn’t prosecute them for.’

To borrow a line from Skip Bayless of ESPN — it’s asinine, asi-ten, asi-leven, asi-twleve

 

0 119

Novus Reaches Milestone in Providing Affordable Medicinal Marijuana Treatment to Arizona Patients Statewide

MIAMI, FL–(Marketwired – Dec 15, 2014) – Novus Acquisition & Development Corp (OTC PINK:NDEV), wholly owned subsidiary Novus Medical Group, Inc., a service provider of the health and wellness savings plan, “Novus MedPlan,” is proud to announce that we have completed our strategic network provider outreach in Arizona. With the awareness that PR Revolution (http://www.prrevolution.com), a public relations and marketing agency who specializes in the cannabis sector, delivered for Novus at the National Marijuana Business Conference last month, Novus was able to exceed expectations for provider enrollment, connect with new providers and execute agreements with more-than-willing dispensaries and wellness clinics. As a result, Novus MedPlan is now ready to assist patients in more states than ever before.

“We have completed our strategic network provider outreach and geographically aligned ourselves throughout the state of Arizona to ensure all of our members have access to Medical Marijuana Clinics and wellness providers within their region, regardless of where in the state they reside,” said Andrea Lopez, Novus President and CEO. “The Novus team is energized about exceeding provider enrollment in Arizona and is continuing its expansion of our Provider Network in Colorado. We plan to continue to build our provider network to strengthen our footprint throughout the country.”

The Novus MedPlan Program is a revolutionary approach to reducing healthcare costs within the MMJ and wellness industry. Individuals and their families can save money on the cost of healthcare-related products and services that are not covered by standard healthcare programs. Patients’ cost-saving plan will be 20% to 50% off for members of Novus MedPlan, which include: doctors’ consultations, alternative medication and medical marijuana in approved states; all for a low fee of $19.95 per month. All patients have the ability to complete their enrollment online 24 hours a day at http://www.novusmedicalgroup.com.

About Novus

Novus Acquisition & Development Corp. (“Novus”) provides health insurance and related insurance solutions to the medical marijuana industry in states where legal programs exist. The Company also plans to offer physicians’ education programs, pharmaceutical R&D, compliance, and business development services within the industry.

NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense put up for sale, put on the market, vend, deliver, supply, circulate, trade, cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional.

The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government’s enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

About PR Revolution
PR Revolution is a full-service public relations and digital marketing agency, with offices in New York City and Livingston, New Jersey. The firm’s seasoned and diverse team offers clients extensive expertise across multiple sectors including cannabis, insurance, fashion and beauty, media and entertainment, food and beverage, travel and hospitality as well as technology. Visithttp://www.prrevolution.com for more information.

Safe Harbor

This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
For Investor Relations contact:
Main Tel: (855) 422-4463
Email: Email Contact

Contact
Novus Acquisition & Development Corp
Gary F. Labrozzi
CEO
855-228-7355
Website: www.ndev.biz or www.novusmedicalgroup.com
Email: Email Contact

0 539

This week has been a roller coaster ride for the marijuana industry. News coming out of Washington D.C pertaining the marijuana reform has been as conflicted as ever. Here is a brief recap of what happened this week.

  1. Congress introduces a spending bill that includes a rider aimed at blocking marijuana legalization in Washington, D.C
  2. The Department of Justice created a new federal policy which lets Native Americans grow and sell marijuana on reservation lands.
  3. President Obama announces his support of the legalization of recreational marijuana in Washington D.C.

Congress to block the legalization of recreational marijuana in Washington D.C

Rep. Andy Harris (Republican-Maryland.) introduced a rider into the spending bill aimed at blocking marijuana legalization in Washington, D.C. The language contained in the rider was very ambiguous and hard to understand by even the members of Congress. Mr. Harris says “none of the funds contained in this Act may be used to enact any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any schedule I substance.” House Appropriations Committee Chairman Hal Rogers (Republican-Kentucky.), said that this spending restriction “prohibits both federal and local funds from being used to implement a referendum legalizing recreational marijuana use in the District.”

Harris stated that the initiative to legalize recreational marijuana will not take effect until it survives congressional review, which does not begin until D.C. Council Chairman Phil Mendelson officially submits the measure to Congress. Then, Congress will have 30 legislative days to pass a joint resolution rejecting the initiative. If Congress fails to pass a resolution during the review period, the initiative takes effect automatically.

On the bright side, the bill that includes the Harris rider, also includes an amendment which prevents the feds from interfering with marijuana reform. This provision was introduced by Rep. Dana Rohrabacher (Republican-California) and it prohibits the Justice Department from spending money to prevent D.C. or the states from “implementing…laws that authorize the use, distribution, possession, or cultivation of medical marijuana.”

greatmjdebate1

DOJ creates new federal policy letting Native Americans grow and sell marijuana on reservation lands

In the midst of all of the commotion, the Department of Justice announced a new federal policy. The policy states that American Indian tribes can grow and sell marijuana on reservation lands. Prior to this announcement only four states (Colorado, Washington, Oregon and Alaska) allowed the sale of recreational marijuana. Now, according to this policy, recreational marijuana can be grown and sold in over 20 states.

There are 326 federally recognized American Indian reservations, according to the Bureau of Indian Affairs. Many of these reservations are in states that don’t allow marijuana for medical or recreational use. These states include Oklahoma, Utah, Wyoming, Florida, Wisconsin, Kansas, Nebraska, North Dakota, South Dakota, Idaho, Texas, Louisiana and Mississippi. 

greatmjdebate2

President Obama supports the legalization of recreational marijuana in Washington D.C.

Americans around the country were not happy with the news from Congress and they let their voice be heard. Only a few hours after the rider was introduced, President Obama announced his support of the legalization of recreational marijuana in Washington D.C. However in an effort to avoid a government shutdown he would sign the funding bill that includes a rider blocking the measure.

D.C. voters approved a referendum in November, by a nearly 2-to-1 margin, to legalize the possession of up to 2 ounces of pot or up to three plants for personal use.

So what is going on?

This news that has come out of Washington D.C. this week has been as conflicting as ever. After reading through language contained in the rider, I was able to find some bright spots. The rider states that funds may not be used to enact any law, rule, or regulation to legalize any schedule I substance. This means that if marijuana is not a schedule I substance, then funds can be used to enact any law, rule, or regulation. This makes the removal of the schedule I label and even bigger catalyst for the cannabis industry.

In late October, United States District Judge Kimberly Mueller listened to testimonies during a five day evidentiary hearing aimed at determining if the Schedule I label slapped on the cannabis plant by the Drug Enforcement Administration in 1970 is unconstitutional. Judge Mueller is expected to deliver her verdict in early 2015. Only time will tell if this rider is able to stop the legal marijuana train running through the United States.

 

0 514

It has been a historic week in Congress for legal hemp cultivation and medical marijuana programs.

The most recent federal spending bill was released on Tuesday and included are amendments that would stop the DEA from using funds to impede with state-legal industrial hemp research. The amendments would also stop the Department of Justice from using funds to go after state medical marijuana programs.

“The enactment of this legislation will mark the first time in decades that the federal government has curtailed its oppressive prohibition of marijuana and has instead taken an approach to respect the many states that have permitted the use of medical marijuana to some degree,” Rep. Dana Rohrabacher (R-Calif.), who in May introduced the medical marijuana protections amendment with co-sponsor Rep. Sam Farr (D-Calif.).

“This is a victory for so many, including scores of our wounded veterans, who have found marijuana to be an important medicine for some of the ailments they suffer, such as PTSD, epilepsy and MS,” Rohrabacher added.

The bill would offer protection for the 23 sates that have legalized medical marijuana programs, in addition to the 11 states where CBD oil is legal. CBD is the non-psychoactive component of marijuana that has been shown to be especially helpful for severe cases of epilepsy.

Some of the most recent studies showing the benefits of medical cannabis have reported it has been beneficial in attacking some aggressive forms of cancer. Cannabis has also shown benefits to blood sugar control and might possibly slow the spread of HIV.

Despite the large number of advocates in Congress and across the country for medical and recreational marijuana, the DEA still classifies it as a Schedule 1 substance with “currently no accepted medical use”. And state compliant medical dispensaries have continually been raided under the current Obama administration.

Hemp, the same plant species as marijuana, but with little, if any THC, also gained some protections in the spending bill. President Obama signed the farm bill into law in February, which allowed for the legalization of industrial hemp production in states that allow it.

There are eighteen states so far with legal industrial hemp production and more than a dozen are working on legislation to get approval for research or legalization of growing industrial hemp.

“For the first time, Congress is letting states set their own medical marijuana and hemp policies, a huge step forward for sensible drug policy,” said Bill Piper, director of national affairs for the Drug Policy Alliance. “States will continue to reform their marijuana laws and Congress will be forced to accommodate them. It’s not a question of if, but when, federal marijuana prohibition will be repealed.”

The spending bill comes into play now as effort by Congress to prevent a government shutdown, as the current spending bill expires on Thursday. The medical marijuana and hemp portions of the bill are just two of many political issues covered in the bill.

It wasn’t all-good news as far is marijuana is concerned in the bill however. The bill did include a rider that would overrule the recent legalization of recreational marijuana in Washington D.C. There have been some issues with the language of the rider however, and advocates for legal marijuana in the nations capital are hoping the measure, which passed last month with 70 percent of District voters, will stay as is on a technicality.

0 126

Easton Pharmaceuticals Initiates Discussions With Canadian Medical Marijuana Association / Club

TORONTO, ON–(Marketwired – Dec 10, 2014) – Easton Pharmaceuticals (OTC: EAPH) announces it has started discussions with a Canadian Medical Marijuana Club.

Alongside its other business segments, Easton has been seeking acquisition targets in the areas of legal marijuana grow operations, patient access, patentable marijuana plant strains in the United States as well as Canada. As a result, Easton has initiated discussions with a Private Medical Marijuana Club, located in Toronto, Canada regarding a direct capital investment. This Club currently has a database of members as well as existing relationships with MMPR Licensed providers. The Marijuana club currently contains a database of members / patients with medical diagnosis and prescriptions who are able to match and provide patients with appropriate strains of Marijuana as well as match provider’s who might have those strains available for sale at the time. The club can be more efficient at contacting and informing any members if a batch is recalled providing a layer of safety to its members.

Easton Management believes that having access to patients will be the key to being successful in the Canadian Marketplace. Health Canada has taken a very draconian stance on MMPR’s and how they are allowed to market Marijuana as it’s scheduled as a narcotic in Canada.

Health Canada has issued warning letters to nearly every MMPR license holder towards their marketing practices.

“On November 25, 2014, Health Canada issued warning letters to 20 licensed producers regarding their advertising practices. These warning letters are in follow-up to an advertising bulletin sent to all licensed producers on June 30, 2014, that outlined the general prohibitions against the advertising of Cannabis contained in the Marihuana for Medical Purposes Regulations (MMPR), the Food and Drugs Act (FDA) and the Narcotic Control Regulations (NCR).

As a result of these prohibitions, the information provided by licensed producers to the public should be limited to basic information for prospective clients such as the brand name, proper or common name of the strain, the price per gram, the cannabinoid content, and the company’s contact information.

The licensed producers listed below have been given until January 12, 2015, to come into compliance with the advertising prohibitions following which, Health Canada will initiate appropriate enforcement action. Health Canada will update this list as licensed producers become compliant.

Clients should be aware that licensed producers who do not comply with the provisions in the FDA or the NCR can be subject to compliance and enforcement action, including suspension and possible revocation of the license or possible prosecution.”

http://www.hc-sc.gc.ca/dhp-mps/marihuana/info/list-eng.php

Licensed producers for which Health Canada has issued warning letters

The companies listed have been issued warning letters and have until January 12, 2015, to come into compliance.

  • Bedrocan Canada Inc.
  • Broken Coast Cannabis Ltd.
  • CannMedica Pharma Inc.
  • CanniMed Inc.
  • Delta 9 Bio-Tech Inc.
  • In the Zone Produce Ltd.
  • MariCann Inc.
  • MedReleaf Corp.
  • Mettrum Ltd.
  • OrganiGram Inc.
  • Prairie Plant Systems Inc.
  • The Peace Naturals Project Inc.
  • ThunderBird Biomedical Inc.
  • Tilray
  • Tweed Inc.
  • Whistler Medical Marijuana Corp.

Additional Information on Easton Pharmaceuticals Inc can be found at

About Easton Pharmaceuticals

Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The Company previously owned an FDA approved wound healing drug and currently owns topically-delivered drugs and therapeutic / cosmetic healthcare products focused on cancer and other health issues geared towards female sexual dysfunction, wound healing, pain, motion sickness and other conditions that are all in various stages of development. The company has ventured into the potentially lucrative medical marijuana industry through an investment into AMFIL Technologies and their groZONE anti-bacterial system and the exclusive option to purchase up to 49% in a medical marijuana grow-op business / facility which has received a letter to build from Health Canada. The company’s gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.

For More Information Visit:

http://www.eastonpharmaceuticalsinc.com

https://finance.yahoo.com/q?s=eaph

https://twitter.com/eastonpharma

Safe Harbor

This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The “Act”). In particular, when certain words or phrases such as “hope”, “positive”, “anticipate,” “pleased,” “plan,” “confident that,” “believe,” “expect,” “possible” or “intent to” and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative and may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company’s products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company’s financial reports and filings.

Contact:
Carla Pepe
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email: info@eastonpharmaceuticalsinc.com